Alvotech Lists Shares in Stockholm as Market Sentiment Improves

Icelandic biotechnology group Alvotech SA started the trading of its shares in Stockholm on Monday to tap into the strength in depth of the Nordic’s nation’s investor base.

“Sweden has among the most biotech companies in the world,” said Chief Executive Officer Robert Wessman in an interview. “So we felt that the knowledge of investors here is much broader than what we usually see.”

The company, which specializes in drugs that mimic the functionality of older drugs, saw revenues more than quadruple to $492 million last year. Less than two weeks ago it raised its annual forecast after strong responses ...